Abstract
New quinoline derivatives based on the allyl and amino acid were prepared and characterized using elemental analysis, 1HNMR, 13CNMR spectra. Docking studies of synthesized compounds were performed in order to explore their binding with HepG2 (code: 5EQG protein) as human liver carcinoma. Some synthesized compounds were evaluated for them in vitro cytotoxic activity against the hepatic carcinoma cell line (HepG2). Among the tested compounds, compound 15d exhibited the most promising profile, being able to inhibit HepG2 (IC50 = 6.529 µg/ml).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
